J&J’s single-dose COVID-19 vaccine approved for emergency use in India

09 August 2021 | Monday | News

Johnson and Johnson’s single-dose COVID-19 vaccine has been given approval for emergency use in the country

In a tweet, Health Minister Mansukh Mandaviya said, now India has five Emergency Use Authorization vaccines. He added that this will further boost the country’s collective fight against COVID-19.

The nation of 1.3 billion people has administered 500 million vaccine doses so far, but barely eight percent of the population has had two shots.

Johnson and Johnson's vaccine is the fifth to be approved after Oxford-AstraZeneca's Covishield, the home developed Covaxin, Russia's Sputnik V, and the US-made Moderna jab.

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in